JP2024513391A5 - - Google Patents

Info

Publication number
JP2024513391A5
JP2024513391A5 JP2023560496A JP2023560496A JP2024513391A5 JP 2024513391 A5 JP2024513391 A5 JP 2024513391A5 JP 2023560496 A JP2023560496 A JP 2023560496A JP 2023560496 A JP2023560496 A JP 2023560496A JP 2024513391 A5 JP2024513391 A5 JP 2024513391A5
Authority
JP
Japan
Prior art keywords
lys
1peg2
diacid
pharmaceutically acceptable
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023560496A
Other languages
English (en)
Japanese (ja)
Other versions
JP7849383B2 (ja
JP2024513391A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/022817 external-priority patent/WO2022212700A2/en
Publication of JP2024513391A publication Critical patent/JP2024513391A/ja
Publication of JP2024513391A5 publication Critical patent/JP2024513391A5/ja
Priority to JP2026028383A priority Critical patent/JP2026083122A/ja
Application granted granted Critical
Publication of JP7849383B2 publication Critical patent/JP7849383B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023560496A 2021-04-01 2022-03-31 コンジュゲートされたヘプシジン模倣物 Active JP7849383B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026028383A JP2026083122A (ja) 2021-04-01 2026-02-25 コンジュゲートされたヘプシジン模倣物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163169545P 2021-04-01 2021-04-01
US63/169,545 2021-04-01
US202263325328P 2022-03-30 2022-03-30
US63/325,328 2022-03-30
PCT/US2022/022817 WO2022212700A2 (en) 2021-04-01 2022-03-31 Conjugated hepcidin mimetics

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026028383A Division JP2026083122A (ja) 2021-04-01 2026-02-25 コンジュゲートされたヘプシジン模倣物

Publications (3)

Publication Number Publication Date
JP2024513391A JP2024513391A (ja) 2024-03-25
JP2024513391A5 true JP2024513391A5 (cg-RX-API-DMAC7.html) 2025-03-06
JP7849383B2 JP7849383B2 (ja) 2026-04-21

Family

ID=83459967

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023560496A Active JP7849383B2 (ja) 2021-04-01 2022-03-31 コンジュゲートされたヘプシジン模倣物
JP2026028383A Pending JP2026083122A (ja) 2021-04-01 2026-02-25 コンジュゲートされたヘプシジン模倣物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026028383A Pending JP2026083122A (ja) 2021-04-01 2026-02-25 コンジュゲートされたヘプシジン模倣物

Country Status (7)

Country Link
US (1) US20240209053A1 (cg-RX-API-DMAC7.html)
EP (1) EP4314014A4 (cg-RX-API-DMAC7.html)
JP (2) JP7849383B2 (cg-RX-API-DMAC7.html)
AU (1) AU2022249097A1 (cg-RX-API-DMAC7.html)
CA (1) CA3214153A1 (cg-RX-API-DMAC7.html)
TW (1) TW202304952A (cg-RX-API-DMAC7.html)
WO (1) WO2022212700A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4091624A1 (en) 2013-03-15 2022-11-23 Protagonist Therapeutics, Inc. Hepcidin analogues and uses thereof
CA2949215C (en) 2014-05-16 2023-03-14 Protagonist Therapeutics, Inc. .alpha.4.beta.7 integrin thioether peptide antagonists
SG10201810154WA (en) 2014-07-17 2018-12-28 Protagonist Therapeutics Inc Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
WO2018022937A1 (en) 2016-07-27 2018-02-01 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases
WO2019157268A1 (en) 2018-02-08 2019-08-15 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
MX2022008740A (es) 2020-01-15 2022-09-23 Janssen Biotech Inc Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
AU2021383828A1 (en) 2020-11-20 2023-07-06 Janssen Pharmaceutica Nv Compositions of peptide inhibitors of interleukin-23 receptor
KR20240034224A (ko) 2021-07-14 2024-03-13 얀센 바이오테크 인코포레이티드 인터류킨-23 수용체의 지질화된 펩티드 억제제
EP4472995A4 (en) * 2022-02-02 2025-11-19 Protagonist Therapeutics Inc Conjugated hepcidin mimetics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192713B1 (en) * 1999-05-18 2007-03-20 President And Fellows Of Harvard College Stabilized compounds having secondary structure motifs
WO2002079235A2 (en) * 2001-03-30 2002-10-10 University Of Copenhagen Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease
WO2007093013A1 (en) * 2006-02-17 2007-08-23 Monash University Methods for the synthesis of dicarba bridges in organic compounds
WO2010065815A2 (en) * 2008-12-05 2010-06-10 The Regents Of The University Of California Mini-hepcidin peptides and methods of using thereof
SG10201810154WA (en) * 2014-07-17 2018-12-28 Protagonist Therapeutics Inc Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
CA3009834A1 (en) * 2015-12-30 2017-07-06 Protagonist Therapeutics, Inc. Analogues of hepcidin mimetics with improved in vivo half lives
WO2019157268A1 (en) * 2018-02-08 2019-08-15 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics

Similar Documents

Publication Publication Date Title
JP2023536463A5 (cg-RX-API-DMAC7.html)
JP2024513392A5 (cg-RX-API-DMAC7.html)
JP2023540679A5 (cg-RX-API-DMAC7.html)
US20240209024A1 (en) Conjugated hepcidin mimetics
JP7849383B2 (ja) コンジュゲートされたヘプシジン模倣物
JP2026012422A (ja) コンジュゲート型ヘプシジン模倣体
JP2009532384A5 (cg-RX-API-DMAC7.html)
JP2012530145A5 (cg-RX-API-DMAC7.html)
WO2017117411A1 (en) Analogues of hepcidin mimetics with improved in vivo half lives
CA3213688A1 (en) Conjugated hepcidin mimetics
WO2022212698A1 (en) Conjugated hepcidin mimetics
JP2024520861A (ja) 遺伝性ヘモクロマトーシスの治療のためのヘプシジン模倣体
JP2009532385A5 (cg-RX-API-DMAC7.html)
JP2024520861A5 (cg-RX-API-DMAC7.html)
US20250170216A1 (en) Conjugated hepcidin mimetics
KR100360975B1 (ko) 위장운동자극활성을가지는폴리펩티드
JP2009519945A5 (cg-RX-API-DMAC7.html)
RU2006101720A (ru) Фармацевтическая композиция
JP5279021B2 (ja) Gpr54アゴニスト活性を有する新規化合物
AR125266A1 (es) Miméticos de hepcidina conjugados
IE912378A1 (en) Derivatives of pituitary posterior lobe hormones
SE501678C2 (sv) Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
NZ822560B2 (en) Novel triple glp-1/gip/glucagon receptor agonist and a pharmaceutical composition for preventing or treating obesity comprising the same
NZ822560A (en) Novel triple glp-1/gip/glucagon receptor agonist and a pharmaceutical composition for preventing or treating obesity comprising the same
WO2025226506A1 (en) Mono- and dual-agonist compounds of human glp1r and gipr for obesity & t2dm